Stocks Comparison
biote vs Usana Health Sciences: revenue, profit, margins and growth compared
biote brought in $192.2M of revenue in fiscal 2025, Usana Health Sciences $925.3M in fiscal 2025. Revenue changed by -2.5% at biote and +8.3% at Usana Health Sciences on the year before, so Usana Health Sciences grew faster. biote kept 14.1% of its revenue as net profit, Usana Health Sciences 1.2%. Free cash flow was $30.2M at biote and $8.5M at Usana Health Sciences.
Side by side, latest fiscal year
| BTMD | USNA | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (January 3, 2026) |
| Revenue | $192.2M | $925.3M |
| Revenue growth | -2.5% | +8.3% |
| Net income | $27M | $10.8M |
| Net margin | 14.1% | 1.2% |
| Free cash flow | $30.2M | $8.5M |
| Free cash flow margin | 15.7% | 0.9% |
| Earnings per share (diluted) | $0.74 | $0.58 |
| Cash | $24.1M | $158.4M |
| Debt | $103.1M | n/a |
| Price to earnings | 1.6 | 25.0 |
| Market value | $43.8M | $267.9M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #256 of 523 · Health care | #150 of 523 · Health care |
Over the years
Questions about biote and Usana Health Sciences
Which is bigger by revenue, biote or Usana Health Sciences?
Usana Health Sciences is bigger by revenue: $925.3M in fiscal 2025, against $192.2M for biote in fiscal 2025.
Which keeps more of its revenue as profit, biote or Usana Health Sciences?
biote had a net margin of 14.1% in fiscal 2025; Usana Health Sciences had 1.2% in fiscal 2025.
Which grew revenue faster, biote or Usana Health Sciences?
In their latest fiscal years revenue changed by -2.5% at biote and +8.3% at Usana Health Sciences.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.